S

SomaLogic

495 employees

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
protein binding reagents
drug discovery and development
multiplex assays
Health Diagnostics
Health Care
aptamer
protein biomarker discovery
clinical and companion diagnostics
normal and disease biology
translational research

Date founded

2000

Funding rounds raised

Total raised

$375M

from 30 investors over 30 rounds

S

SomaLogic raised $375M on September 1, 2021

Investors: Novartis Japan, Casdin Capital, LLC, T. Rowe Price, Corvex Connected Worker™, Perceptive Advisors and Farallon Capital Management

S

SomaLogic raised $81M on December 23, 2020

Investors: ＮＥＣソリューションイノベータ（株）, Logos Global Management, LP, Revelation Partners, Boston Millennia Partners, Intermountain Ventures, Millennium Partners and Redmile Group

S

SomaLogic raised $121M on November 25, 2020

Investors: Madryn Asset Management, Reimagined Ventures, Casdin Capital, LLC, Foresite Capital, Soleus Capital Management, L.P., Farallon Capital Management, Monashee Investment Management LLC and T. Rowe Price

S

SomaLogic raised $200M on January 3, 2018

Investors: ProQuest Investments, Nan Fung Life Sciences, Madryn Asset Management, Quest Diagnostics, iCarbonX and Otsuka Holdings Co., Ltd.

S

SomaLogic raised $17M on November 17, 2014

Investors: ProQuest Investments

S

SomaLogic raised $1M on June 4, 2014

Investors: Bill & Melinda Gates Foundation

S

SomaLogic raised undisclosed on January 1, 2014

Investors: dRx data

FAQ